2017
DOI: 10.1158/0008-5472.can-16-3242
|Get access via publisher |Cite
|
Sign up to set email alerts

Mcl-1 Degradation Is Required for Targeted Therapeutics to Eradicate Colon Cancer Cells

"VSports app下载" Abstract: The Bcl-2 family protein Mcl-1 is often degraded in cancer cells subjected to effective therapeutic treatment, and defective Mcl-1 degradation has been associated with intrinsic and acquired drug resistance. However, a causal relationship between Mcl-1 degradation and anticancer drug responses has not been directly established, especially in solid tumor cells where Mcl-1 inhibition alone is insufficient to trigger cell death. In this study, we present evidence that Mcl-1 participates directly in determining ef… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
128
0

Year Published

2017
2017
2019
2019

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations

Cited by 136 publications (V体育ios版)

(132 citation statements)
references

References 49 publications

4
128
0
Order By: Relevance